Avalo Therapeutics (AVTX) Cash from Financing Activities (2014 - 2026)
Avalo Therapeutics posted quarterly Cash from Financing Activities of $1.4 million for Q1 2026, up 103.64% on a QoQ basis from $687000.0 in Q4 2025.
Avalo Therapeutics (AVTX) has 13 years of Cash from Financing Activities data on file, last reported at $1.4 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities changed N/A year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $16.0 million (down 76.22% YoY), and the FY2025 full-year result was $14.6 million, down 91.7% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $1.4 million, up from $687000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $108.6 million in Q1 2024 and bottomed at -$14.8 million in Q2 2022.
- The 5-year median for Cash from Financing Activities is $687000.0 (2025), against an average of $15.6 million.
- Peak annual rise in Cash from Financing Activities reached 6770800.0% in 2024, while the deepest fall reached 178.93% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at $82000.0 in 2022, then plunged by 98.78% to $1000.0 in 2023, then surged by 6770800.0% to $67.7 million in 2024, then sank by 98.99% to $687000.0 in 2025, then surged by 103.64% to $1.4 million in 2026.
- The last three Cash from Financing Activities figures came in at $1.4 million (Q1 2026), $687000.0 (Q4 2025), and $14.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - | 1.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.40 Mn |
| Mar 31, 2026 | 1.40 Mn |
| Dec 31, 2025 | 687,000.00 |
| Dec 31, 2025 | 687,000.00 |
| Sep 30, 2025 | 14.37 Mn |
| Sep 30, 2025 | 14.37 Mn |
| Jun 30, 2025 | -469,000.00 |
| Jun 30, 2025 | -469,000.00 |
| Dec 31, 2024 | 67.71 Mn |
| Dec 31, 2024 | 67.71 Mn |
| Jun 30, 2024 | -472,000.00 |
| Jun 30, 2024 | -472,000.00 |
| Mar 31, 2024 | 108.61 Mn |
| Mar 31, 2024 | 108.61 Mn |
| Dec 31, 2023 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 10.70 Mn |
| Sep 30, 2023 | 10.70 Mn |
| Jun 30, 2023 | 598,000.00 |
| Jun 30, 2023 | 598,000.00 |
| Mar 31, 2023 | 13.75 Mn |
| Mar 31, 2023 | 13.75 Mn |
| Dec 31, 2022 | 82,000.00 |
| Dec 31, 2022 | 82,000.00 |
| Jun 30, 2022 | -14.78 Mn |
| Jun 30, 2022 | -14.78 Mn |
| Dec 31, 2021 | 76,000.00 |
| Dec 31, 2021 | 76,000.00 |
| Sep 30, 2021 | 47.64 Mn |
| Sep 30, 2021 | 47.64 Mn |
| Jun 30, 2021 | 21.22 Mn |
| Jun 30, 2021 | 21.22 Mn |
| Mar 31, 2021 | 37.83 Mn |
| Mar 31, 2021 | 37.83 Mn |
| Dec 31, 2020 | 200,000.00 |
| Dec 31, 2020 | 200,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Jun 30, 2020 | 35.49 Mn |
| Jun 30, 2020 | 35.49 Mn |
| Mar 31, 2020 | 9.10 Mn |
| Mar 31, 2020 | 9.10 Mn |
| Dec 31, 2019 | 135,502.00 |
| Dec 31, 2019 | 135,502.00 |
| Sep 30, 2019 | 3.51 Mn |
| Sep 30, 2019 | 3.51 Mn |
| Jun 30, 2019 | 97,200.00 |
| Jun 30, 2019 | 97,200.00 |
| Mar 31, 2019 | 8.82 Mn |
| Mar 31, 2019 | 8.82 Mn |
| Dec 31, 2018 | 6.17 Mn |
| Dec 31, 2018 | 6.17 Mn |
| Sep 30, 2018 | 3.84 Mn |
| Sep 30, 2018 | 3.84 Mn |
| Jun 30, 2018 | 35,483.00 |
| Jun 30, 2018 | 35,483.00 |
| Mar 31, 2018 | 363,390.00 |
| Mar 31, 2018 | 363,390.00 |
| Dec 31, 2017 | 11,430.00 |
| Dec 31, 2017 | 11,430.00 |
| Sep 30, 2017 | -606,611.00 |
| Sep 30, 2017 | -606,611.00 |
| Jun 30, 2017 | 4.21 Mn |
| Jun 30, 2017 | 4.21 Mn |
| Mar 31, 2017 | 120,959.00 |
| Mar 31, 2017 | 120,959.00 |
| Dec 31, 2016 | 34,972.00 |
| Dec 31, 2016 | 34,972.00 |
| Sep 30, 2016 | 376,079.00 |
| Sep 30, 2016 | 376,079.00 |
| Jun 30, 2016 | -992,171.00 |
| Jun 30, 2016 | -992,171.00 |
| Mar 31, 2016 | -844,868.00 |
| Mar 31, 2016 | -844,868.00 |
| Dec 31, 2015 | 21.40 Mn |
| Dec 31, 2015 | 21.40 Mn |
| Sep 30, 2015 | -1.00 Mn |
| Sep 30, 2015 | -1.00 Mn |
| Jun 30, 2015 | -783,454.00 |
| Jun 30, 2015 | -783,454.00 |
| Mar 31, 2015 | -15,796.00 |
| Mar 31, 2015 | -15,796.00 |
| Dec 31, 2014 | -21,437.00 |
| Dec 31, 2014 | -21,437.00 |